explore -WSS

explore

author：comprehensive 2025-09-30 08:49:51 - browse：7

prostate cancer cells — Prostate cancer cells seen under the microscope. NIH

Prostate cancer tends to be the tortoise of tumors, growing and spreading slowly. When cancerous cells escape the golf ball-sized prostate, they can lodge in various places throughout the body. New research shows that where these cells go can affect how long a man survives.

When prostate cancer spreads, or metastasizes, about three-quarters of the time it takes up residence in the bones. Less common locations are the lungs, liver, and lymph nodes.

An international team of researchers pooled information from nine clinical trials to estimate the average survival times for men with prostate cancer that had spread to four different tissues. Metastasis to the lymph nodes was linked to the longest survival; metastasis to the liver led to the shortest.

“This important study confirms that one size does not fit all when it comes to metastatic prostate cancer,” said Dr. Marc Garnick, a prostate cancer specialist at Beth Israel Deaconess Medical Center in Boston.

The new study, led by Susan Halabi, a professor of biostatistics at Duke University School of Medicine, suggests that prostate cancer that skips the bones and spreads to the liver and lungs may represent a different disease than prostate cancer that invades bones or lymph nodes. The results were published Monday in the Journal of Clinical Oncology.

Median survival for metastatic prostate cancer is affected by metastasis site. Mark Dubowski for Duke Health

“A better understanding of how metastatic prostate cancer behaves in different locations is letting us tailor diagnostic approaches and treatments that we hope will improve outcomes,” Garnick said.

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Change Healthcare cyberattack prompts Medicare loan program

WSS

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

Novo Nordisk obesity pill bests Wegovy in early trial

Maui funeral service workers on devastation of fires: 'I'm in shock'

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

focus

explore

leisure time

Peter Hotez and the public health issue of online harassment

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

United colonoscopy coverage change 'may cost lives,' doctors say

Amylyx ALS drug failure raises questions and concerns

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Pharma budget tightening trickles down to Doximity

After affirmative action ruling, medical educators look to 'holistic review'

The drug industry has found itself all alone in Washington

Peter Hotez and the public health issue of online harassment

CDC overhauls leadership of center that led response to Covid

Wikipedia

Large hospital system sues Multiplan for low

IVF, abortion rights issues kick off Biden’s State of the Union

Who are the detained American citizens released from prison in Iran?

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Large hospital system sues Multiplan for low

Just how do doctors, lawmakers, and the public define abortion?

focus

hotspot

leisure time

leisure time